Prentice Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,007	Closed	-$227K	–	111
2024 Q4	$227K	Buy	4,007 +22	+0.6%	+$1.23K	0.07%	103
2024 Q3	$206K	Sell	3,985 -3,012	-43%	-$141K	0.06%	106
2024 Q2	$291K	Sell	6,997 -254	-4%	-$11.4K	0.09%	97
2024 Q1	$393K	Buy	7,251 +757	+12%	+$38.6K	0.14%	84
2023 Q4	$333K	Buy	6,494 +132	+2%	+$6.93K	0.13%	87
2023 Q3	$369K	Buy	6,362 +79	+1%	+$4.84K	0.17%	75
2023 Q2	$402K	Buy	6,283 +850	+16%	+$57K	0.18%	74
2023 Q1	$377K	Buy	5,433 +252	+5%	+$17.8K	0.18%	68
2022 Q4	$373K	Buy	5,181 +283	+6%	+$21.3K	0.19%	63
2022 Q3	$349K	Buy	+4,898	New	+$355K	0.19%	55
2022 Q2	–	Sell	-3,844	Closed	-$278K	–	148
2022 Q1	$278K	Buy	+3,844	New	+$258K	0.13%	75
2021 Q4	–	Sell	-3,520	Closed	-$208K	–	126
2021 Q3	$208K	Buy	3,520 +31	+0.9%	+$2.04K	0.1%	100
2021 Q2	$233K	Buy	3,489 +1,232	+55%	+$80.3K	0.12%	93
2021 Q1	$142K	Buy	+2,257	New	+$140K	0.08%	111